Biz in Saigon

What is the Key for Vietnam to become an International Financial Center?

Discussing the competitiveness of proposed International Financial Centers (IFCs) in Ho Chi Minh City (HCMC) and Da Nang compared to global hubs, Dr. Nguyen Tu Anh, Director of Policy Research at VinUni University, stressed that Vietnam must clearly [...]

Read more

Latest News

Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines

MIAMI, Jan. 13, 2026 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the [...]

Ocugen to Host Webcast on Thursday, January 15 at 8:30 a.m. ET to Discuss OCU410 Phase 2 Clinical Trial Data

MALVERN, Pa., Jan. 13, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: [...]

Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

KT-621 BROADEN2 Phase 2b trial in AD ongoing, with data expected by mid-2027 KT-621 BREADTH [...]

SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity

SciSparc intends to commence commercialization of these patented technologies immediately following the transaction closing TEL [...]

Robotin R2 Pro Sweeps “Best of CES” Awards; Heralds a New Era in 150-Year History of Carpet Washing

LAS VEGAS, Jan. 13, 2026 /PRNewswire/ — Following a breakout debut at CES 2026, Robotin [...]

Most Read

Don’t miss it

Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines

MIAMI, Jan. 13, 2026 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the [...]

Ocugen to Host Webcast on Thursday, January 15 at 8:30 a.m. ET to Discuss OCU410 Phase 2 Clinical Trial Data

MALVERN, Pa., Jan. 13, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: [...]

Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

KT-621 BROADEN2 Phase 2b trial in AD ongoing, with data expected by mid-2027 KT-621 BREADTH [...]

SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity

SciSparc intends to commence commercialization of these patented technologies immediately following the transaction closing TEL [...]

Robotin R2 Pro Sweeps “Best of CES” Awards; Heralds a New Era in 150-Year History of Carpet Washing

LAS VEGAS, Jan. 13, 2026 /PRNewswire/ — Following a breakout debut at CES 2026, Robotin [...]